Cannabis producer Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced its financial results on Tuesday for the third quarter ended June 30, 2024, revealing net revenue increased 25% year-over-year to CA$41.1 million ($29.9 million). Beena Goldenberg, the company's CEO, praised the revenue milestone. "We are pleased to report a strong third quarter, highlighted by a 25% year-over-year increase in net revenue, and a significant improvement in adjusted EBITDA", she stated. In May, Organigram announced its second international medical cannabis customer in the UK, Avida Medical, a full-service medical cannabis and special medicines manufacturing business. In June, the company announced a strategic investment aimed at expanding its presence in Germany, one of the burgeoning European cannabis markets. The Toronto-based company reported that it will utilize proceeds from its Jupiter strategic investment pool and invest €14 million ($15 million) initially. The sum includes €11.5 million via an unsecured convertible note and €2.5 million to purchase equity interests from existing ...